Comparison of Bacterial Risk in Cryo AHF and Pathogen Reduced Cryoprecipitated Fibrinogen Complex

Comparison of Bacterial Risk in Cryo AHF and Pathogen Reduced Cryoprecipitated Fibrinogen Complex

Until November 2020, cryoprecipitated antihaemophilic factor (cryo AHF) was the only United States Food and Drug Administration (FDA)-approved fibrinogen source to treat acquired bleeding. The post-thaw shelf life of cryo AHF is limited, in part, by infectious disease risk. Concerns over product was...

Full description

Bibliographic Details
Main Authors: Thea Lu, Pallavi Nahata, Aja Johnson, Nadia Keltner, Lindsay Peters, Melissa McCormack, Bianca Muñoz, Mary Krath, Elan Weiner, Peter Bringmann
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Pathogens
Subjects:
fibrinogen
cryo AHF
cryoprecipitated antihaemophilic factor
INTERCEPT
hemorrhage
trauma
Online Access:https://www.mdpi.com/2076-0817/11/7/744

Internet

https://www.mdpi.com/2076-0817/11/7/744

Similar Items